NORD's
Washington Office
 Check here to read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.
|
|
|
|
NORD Events
NORD Tribute Banquet
Washington, DC: Capital Hilton Hotel
May 6, 2002
2002 Honorees
The NORD Corporate Leadership Awards
Actelion Pharmaceuticals US Inc.
...for the development of Tracleer„· for the treatment of pulmonary arterial hypertension (PAH).
Novartis Pharmaceuticals
...for the development of Gleevec„· for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs)
Millennium and ILEX Oncology, Inc.
...for the development of CAMPATH„µ for the treatment of chronic lymphocytic leukemia (CLL)
The NORD Public Health Leadership Award
Linda A. Suydam, DPA
...Senior Associate Commissioner, U.S. Food and Drug Administration (FDA)
The NORD Humanitarian Award
The Medtronic Foundation
...for recognizing the needs of the patient community and working with voluntary health agencies to develop programs that improve the lives of people with rare disorders
The NORD Patient Access Award
AstraZeneca
...for the development of an innovative and compassionate Early Access Program for Iressa„· simultaneous with active enrollment of patients for controlled clinical trials
The NORD National Health Leadership Award
Representative John M. Shimkus (R-IL) and Henry Waxman (D-CA) for their sponsorship of the Rare Diseases Act of 2002.
Representative Mark Foley (R-FL) and Henry Waxman (D-CA) for their sponsorship of the Rare Diseases Orphan Product Development Act.
|
|
|
|
Since 1983, working toward the prevention, treatment, and cure of rare
“orphan” diseases.
|
 Worth Magazine
named NORD one of America's top 100 charities. Make your donation and help 25 million Americans with rare disorders.
Tribute Banquet
NORD honors members of Congress, scientists, and pharmaceutical firms for advances in rare-disease therapies at its annual Tribute Banquet in Washington, DC.
[Go to Article]
|
